Science Explorer Back to mapMap
Discussion
Topic · Blood Pressure and Hypertension Studies

Most cited papers in Blood Pressure and Hypertension Studies

Blood Pressure and Hypertension Studies

What are the most cited papers in Blood Pressure and Hypertension Studies?

The most cited paper in Blood Pressure and Hypertension Studies is "The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report" (Aram V. Chobanian, 2003), with 25,591 citations. Next come "Prediction of Creatinine Clearance from Serum Creatinine" (15,456) and "2013 ESH/ESC Guidelines for the management of arterial hypertension" (13,694).

Showing 50 of 97 papers. Every paper with more than 2,159 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report Aram V. Chobanian · JAMA 20 May 2003 25,591
2 Prediction of Creatinine Clearance from Serum Creatinine Donald W. Cockcroft, Henry Gault · ˜The œNephron journals/Nephron journals 28 Nov 2008 15,456
3 2013 ESH/ESC Guidelines for the management of arterial hypertension Authors Task Force Members et al. · European Heart Journal Open access108 authors 14 Jun 2013 13,694
4 Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Aram V. Chobanian, George L. Bakris, Henry Richard Black et al. · Hypertension Dec 2003 13,366
5 Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association Emelia J. Benjamin et al. · Circulation 25 Jan 2017 12,804
6 Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease? Aimun Ahmed, Tom Jorna, Sunil Bhandari · ˜The œNephron journals/Nephron journals 2016 11,736
7 Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 Gregory A. Roth et al. · Journal of the American College of Cardiology Open access679 authors Dec 2020 11,687
8 2018 ESC/ESH Guidelines for the management of arterial hypertension Bryan Williams et al. · European Heart Journal Open access211 authors 25 Aug 2018 10,602
9 Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients The Heart Outcomes Prevention Evaluation Study Investigators · New England Journal of Medicine Open access 20 Jan 2000 8,696
10 Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Dariush Mozaffarian et al. · PubMed 27 Jan 2015 8,335
11 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults Paul Andrew James, Suzanne Oparil, Barry L. Carter et al. · JAMA 18 Dec 2013 8,073
12 Global burden of hypertension: analysis of worldwide data Patricia M. Kearney, Megan Whelton, Kristi Reynolds et al. · The Lancet 2005 7,745
13 Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy Barry Morton Brenner, Mark Emmanuel Cooper, Dick de Zeeuw et al. · New England Journal of Medicine Open access 20 Sep 2001 7,554
14 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Paul Kieran Whelton et al. · Hypertension 13 Nov 2017 7,461
15 Heart Disease and Stroke Statistics—2012 Update Writing Group Members et al. · Circulation Open access 16 Dec 2011 7,242
16 Heart Disease and Stroke Statistics—2016 Update Dariush Mozaffarian et al. · Circulation 16 Dec 2015 6,664
17 2016 European Guidelines on cardiovascular disease prevention in clinical practice Massimo Francesco Piepoli et al. · European Heart Journal Open access132 authors 23 May 2016 6,563
18 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults Paul Kieran Whelton et al. · Journal of the American College of Cardiology Open access 13 Nov 2017 6,560
19 A Randomized Trial of Intensive versus Standard Blood-Pressure Control The SPRINT Research Group · New England Journal of Medicine Open access 9 Nov 2015 6,353
20 Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings Richard B. Devereux, Daniel Rivera Alonso, Elizabeth M. Lutas et al. · The American Journal of Cardiology Feb 1986 6,278
21 Expert consensus document on arterial stiffness: methodological issues and clinical applications Stéphane Laurent, Jeremy K. Cockcroft, Luc Van Bortel et al. · European Heart Journal 25 Sep 2006 6,089
22 Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine Open access 20 Sep 2001 6,043
23 2007 Guidelines for the Management of Arterial Hypertension Giuseppe Mancia, Guy De Backer, Anna F. Dominiczak et al. · Journal of Hypertension Jun 2007 5,846
24 Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial Lennart Hansson, Alberto Zanchetti, S. George Carruthers et al. · The Lancet Jun 1998 5,794
25 2013 ESH/ESC Guidelines for the management of arterial hypertension Giuseppe Mancia et al. · Journal of Hypertension 18 Jun 2013 5,696
26 Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet Frank M. Sacks, Laura P. Svetkey, William M. Vollmer et al. · New England Journal of Medicine Open access 4 Jan 2001 5,664
27 Heart Disease and Stroke Statistics—2010 Update WRITING GROUP MEMBERS et al. · Circulation 18 Dec 2009 5,604
28 The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy Edmund J. Lewis, Lawrence G. Hunsicker, Raymond P. Bain et al. · New England Journal of Medicine 11 Nov 1993 5,451
29 Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol Björn Dahlöf, Richard B. Devereux, Sverre Erik Kjeldsen et al. · The Lancet Mar 2002 5,432
30 Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence Donald Edward Morisky, Lawrence W. Green, David Michael Levine · Medical Care 1986 5,389
31 Heart Disease and Stroke Statistics—2014 Update Alan S. Go et al. · Circulation Open access 18 Dec 2013 5,239
32 Heart Disease and Stroke Statistics—2013 Update Alan S. Go et al. · Circulation Open access 13 Dec 2012 5,194
33 Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis David Stephen Celermajer, Keld Ejvind Sørensen, Vanda M. Gooch et al. · The Lancet Open access Nov 1992 4,782
34 Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults Daniel H. O’Leary, Joseph F. Polak, Richard A. Kronmal et al. · New England Journal of Medicine Open access 7 Jan 1999 4,720
35 National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification Andrew S. Levey, Josef Coresh, Ethan M. Balk et al. · Annals of Internal Medicine 15 Jul 2003 4,652
36 Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery Mary C. Corretti, Todd J. Anderson, Emelia J. Benjamin et al. · Journal of the American College of Cardiology Open access 2002 4,616
37 Blood pressure, stroke, and coronary heart disease Rory Collins, Richard Peto, Stephen W MacMahon et al. · The Lancet Apr 1990 4,534
38 Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Richard B. Devereux, Nathaniel Reichek · Circulation Open access Apr 1977 4,513
39 New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race Lesley A. Inker et al. · New England Journal of Medicine Open access 23 Sep 2021 4,506
40 Chronic kidney disease: global dimension and perspectives Vivekanand Jha, Guillermo García-García, Kunitoshi Iseki et al. · The Lancet 30 May 2013 4,435
41 Normality Tests for Statistical Analysis: A Guide for Non-Statisticians Asghar Ghasemi, Saleh Zahediasl · Intern J Endocrinol Metab Open access 2 Jul 2012 4,374
42 Blood pressure, stroke, and coronary heart disease *1Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Stephen W MacMahon · The Lancet Mar 1990 4,311
43 The global epidemiology of hypertension Katherine T. Mills, Andrei R Stefanescu, Jiang He · Nature Reviews Nephrology ReviewOpen access 5 Feb 2020 4,225
44 Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis Nathan R. Hill, Samuel Fatoba, Jason Lee Oke et al. · PLoS ONE ReviewOpen access 6 Jul 2016 4,103
45 Recommendations for Blood Pressure Measurement in Humans and Experimental Animals Thomas G. Pickering, John Edward Hall, Lawrence J. Appel et al. · Circulation 7 Feb 2005 4,008
46 Clinical epidemiology of cardiovascular disease in chronic renal disease RN Foley, PS Parfrey, MJ Sarnak · American Journal of Kidney Diseases Nov 1998 3,967
47 Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants Bin Zhou et al. · The Lancet Open access1,145 authors 24 Aug 2021 3,934
48 Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients Stéphane Laurent, Pierre Boutouyrie, Roland G Asmar et al. · Hypertension Open access May 2001 3,860
49 Chronic Kidney Disease Angela Claire Webster, Evi Nagler, Rachael Lisa Morton et al. · The Lancet 22 Nov 2016 3,834
50 Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet Apr 2003 3,799

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.